Literature DB >> 12461776

P53 licensed to kill? Operating the assassin.

Susan Haupt1, Igal Louria-Hayon, Ygal Haupt.   

Abstract

The p53 protein is a key player in the cellular response to stress. Proper regulation of p53 is imperative for the suppression of tumor development. This regulation is largely governed by its master inhibitor, Mdm2, which both blocks p53 activities and promotes its destabilization. This tight regulation of p53 by Mdm2 must be interrupted under stress conditions in order for p53 to be stabilized in an active form. A combined action of partner proteins and modifying enzymes is essential for the relief of p53 from Mdm2. The recent revelation of p53 association with the PML-nuclear bodies provides one explanation of how this regulatory network is coordinated within the nucleus in response to certain stress conditions. Thus, it is not only the nature of the p53 regulatory complex but also the spatial and temporal context of this association that governs the output inhibitory signals mediated by p53. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12461776     DOI: 10.1002/jcb.10311

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.

Authors:  Katelyn M Atkins; Laura L Thomas; Jonathan Barroso-González; Laurel Thomas; Sylvain Auclair; Jun Yin; Hyeog Kang; Jay H Chung; Jimmy D Dikeakos; Gary Thomas
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

2.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

3.  Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.

Authors:  Elizabeth Turpin; Kimberly Luke; Jeremy Jones; Terrence Tumpey; Kouacou Konan; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression.

Authors:  Natalia V Oleinik; Natalia I Krupenko; David G Priest; Sergey A Krupenko
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

5.  Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation.

Authors:  Qingyu Qin; Guanghong Liao; Michel Baudry; Xiaoning Bi
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

6.  Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish.

Authors:  Yi-Lin Yan; Thomas Desvignes; Ruth Bremiller; Catherine Wilson; Danielle Dillon; Samantha High; Bruce Draper; Charles Loren Buck; John Postlethwait
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

7.  Therapeutic strategies for head and neck cancer based on p53 status.

Authors:  Ichiro Ota; Noritomo Okamoto; Katsunari Yane; Akihisa Takahashi; Takashi Masui; Hiroshi Hosoi; Takeo Ohnishi
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

Review 8.  Regulation of apoptosis-related genes by nitric oxide in cancer.

Authors:  Samuel Y Olson; Hermes J Garbán
Journal:  Nitric Oxide       Date:  2008-06-02       Impact factor: 4.427

9.  Prenatal exposure to chromium induces early reproductive senescence by increasing germ cell apoptosis and advancing germ cell cyst breakdown in the F1 offspring.

Authors:  Kirthiram K Sivakumar; Jone A Stanley; Joe A Arosh; Melissa E Pepling; Robert C Burghardt; Sakhila K Banu
Journal:  Dev Biol       Date:  2014-02-12       Impact factor: 3.582

10.  A fetal whole ovarian culture model for the evaluation of CrVI-induced developmental toxicity during germ cell nest breakdown.

Authors:  Jone A Stanley; Joe A Arosh; Robert C Burghardt; Sakhila K Banu
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-05       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.